Literature DB >> 18799802

Quantitative tissue and gene-specific differences and developmental changes in Nat1, Nat2, and Nat3 mRNA expression in the rat.

David F Barker1, Jason M Walraven, Elizabeth H Ristagno, Mark A Doll, J Christopher States, David W Hein.   

Abstract

Human N-acetyltransferase 1 (NAT1) and 2 (NAT2) are important phase II enzymes involved in the biotransformation of xenobiotics. In toxicity and carcinogenicity studies, functional polymorphism of rat N-acetyltransferase is considered a model for similar human variability. To accurately quantitate expression of the three rat N-acetyltransferases, we developed sensitive, specific assays for Nat1, Nat2, and Nat3 mRNAs. In male F344 rats, tissue-specific expression varied over a limited range for both Nat1 (approximately 19-fold) and Nat2 (approximately 30-fold), with the highest expression of both genes in colon. Expression of Nat3 mRNA was at least 2 to 3 orders of magnitude less than that of Nat1 or Nat2. Comparison of Nat1 and Nat2 mRNA expression in bladder, colon, liver, and lung of male and female F344 rats detected no significant gender-specific difference. In Sprague-Dawley and F344 rats ranging in age from neonate to mature adult, colon showed a >10-fold increase in Nat2 during the first postnatal month that did not correlate with changes in Nat1. In contrast, Nat2 showed no developmental change in Sprague-Dawley or F344 liver as Nat1 increased modestly. These measures of rat Nat expression confirm that Nat3 expression is negligible and that Nat1 and Nat2 are the primary determinants of arylamine acetylation activity in all tissues tested. The findings demonstrate differential tissue-specific and developmental regulation of the rat Nat1 and Nat2 genes and contribute to more complete understanding of tissue-, gender-, and development-specific expression patterns of the cognate N-acetyltransferase genes of humans and other species.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799802      PMCID: PMC2596640          DOI: 10.1124/dmd.108.023564

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  25 in total

1.  Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model.

Authors:  D W Hein; T D Rustan; K D Bucher; E J Furman; W J Martin
Journal:  J Pharmacol Exp Ther       Date:  1991-07-01       Impact factor: 4.030

2.  Tissue- and gender-specific expression of N-acetyltransferase 2 (Nat2*) during development of the outbred mouse strain CD-1.

Authors:  L Estrada; K C Kanelakis; G N Levy; W W Weber
Journal:  Drug Metab Dispos       Date:  2000-02       Impact factor: 3.922

3.  Acetylator phenotype-dependent and -independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver.

Authors:  D W Hein; T D Rustan; K D Bucher; W J Martin; E J Furman
Journal:  Drug Metab Dispos       Date:  1991 Sep-Oct       Impact factor: 3.922

4.  Neonatal ontogeny of murine arylamine N-acetyltransferases: implications for arylamine genotoxicity.

Authors:  Charlene A McQueen; Binh Chau
Journal:  Toxicol Sci       Date:  2003-04-15       Impact factor: 4.849

Review 5.  N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis.

Authors:  D W Hein
Journal:  Toxicol Lett       Date:  2000-03-15       Impact factor: 4.372

6.  Prenatal expression of N-acetyltransferases in C57Bl/6 mice.

Authors:  Charlene A McQueen; M Kimberly Mitchell; Lanvi N Dang; Binh Chau; Ronald B Tjalkens; Martin A Philbert
Journal:  Chem Biol Interact       Date:  2003-03-06       Impact factor: 5.192

Review 7.  Acetylator genotype and arylamine-induced carcinogenesis.

Authors:  D W Hein
Journal:  Biochim Biophys Acta       Date:  1988-08-03

8.  Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice.

Authors:  Kim S Sugamori; Sharon Wong; Andrea Gaedigk; Violeta Yu; Hanan Abramovici; Richard Rozmahel; Denis M Grant
Journal:  Mol Pharmacol       Date:  2003-07       Impact factor: 4.436

9.  Structure and transcriptional regulation of the Nat2 gene encoding for the drug-metabolizing enzyme arylamine N-acetyltransferase type 2 in mice.

Authors:  Sotiria Boukouvala; Naomi Price; Kathryn E Plant; Edith Sim
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

10.  Mouse N-acetyltransferase type 2, the homologue of human N-acetyltransferase type 1.

Authors:  Akane Kawamura; Isaac Westwood; Larissa Wakefield; Hilary Long; Naixia Zhang; Kylie Walters; Christina Redfield; Edith Sim
Journal:  Biochem Pharmacol       Date:  2008-01-05       Impact factor: 5.858

View more
  7 in total

1.  Acetylator Genotype-Dependent Dyslipidemia in Rats Congenic for N-Acetyltransferase 2.

Authors:  Kyung U Hong; Mark A Doll; Angeliki Lykoudi; Raúl A Salazar-González; Mariam R Habil; Kennedy M Walls; Alaa F Bakr; Smita S Ghare; Shirish S Barve; Gavin E Arteel; David W Hein
Journal:  Toxicol Rep       Date:  2020-09-28

2.  Systemic functional expression of N-acetyltransferase polymorphism in the F344 Nat2 congenic rat.

Authors:  David W Hein; Jean Bendaly; Jason R Neale; Mark A Doll
Journal:  Drug Metab Dispos       Date:  2008-09-17       Impact factor: 3.922

3.  4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats.

Authors:  Felicia A Jefferson; Gong H Xiao; David W Hein
Journal:  Toxicol Sci       Date:  2008-10-08       Impact factor: 4.849

4.  Analytical investigations of toxic p-phenylenediamine (PPD) levels in clinical urine samples with special focus on MALDI-MS/MS.

Authors:  Gero P Hooff; Nick A van Huizen; Roland J W Meesters; Eduard E Zijlstra; Mohamed Abdelraheem; Waleed Abdelraheem; Mohamed Hamdouk; Jan Lindemans; Theo M Luider
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

5.  Treatment of Rats with Apocynin Has Considerable Inhibitory Effects on Arylamine N-Acetyltransferase Activity in the Liver.

Authors:  Sheena Francis; Nicola Laurieri; Chukwuemeka Nwokocha; Rupika Delgoda
Journal:  Sci Rep       Date:  2016-05-31       Impact factor: 4.379

6.  Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population.

Authors:  Lei Quan; Koushik Chattopadhyay; Heather H Nelson; Kenneth K Chan; Yong-Bing Xiang; Wei Zhang; Renwei Wang; Yu-Tang Gao; Jian-Min Yuan
Journal:  Oncotarget       Date:  2016-06-28

7.  Rate-Determining and Rate-Limiting Steps in the Clearance and Excretion of a Potent and Selective p21-Activated Kinase Inhibitor: A Case Study of Rapid Hepatic Uptake and Slow Elimination in Rat.

Authors:  Peter W Fan; Jacob Z Chen; M Allan Jaochico; Hank La; Ning Liu; Teresa Mulder; Robert T Cass; Matthew Durk; Kirsten Messick; Nicole Valle; Shannon Liu; Wendy Lee; James J Crawford; Joachim Rudolf; Lesley J Murray; S Cyrus Khojasteh; Matthew Wright
Journal:  Drug Metab Lett       Date:  2016
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.